title: Revisiting the ultimate target of treatment for prostate cancer.
authors.affiliation: Division of Clinical Sciences, National Cancer Institute, Bethesda, MD 20892, USA.
authors.forename: William L
authors.initials: WL
authors.lastname: Dahut
authors.forename: Ravi A
authors.initials: RA
authors.lastname: Madan
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D001549:Benzamides; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems; D006801:Humans; D008297:Male; D009570:Nitriles; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D000726:Androgen Antagonists; D001549:Benzamides; D009570:Nitriles; D010669:Phenylthiohydantoin; C540278:enzalutamide